Rob Pieters

39.8k citations

518 papers · 22.9k indexed · 6 hit papers · h-index 79

Impact in

Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Public Health, Environmental and Occupational Health top 0.01%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 204
- Acute Myeloid Leukemia Research 143
- Chronic Myeloid Leukemia Treatments 75
Public Health, Environmental and Occupational Health 356
- Acute Lymphoblastic Leukemia research 343

Co-authors: Monique L. den Boer A. Veerman Marry M. van den Heuvel‐Eibrink Gertjan J.L. Kaspers Jules P.P. Meijerink Lewis B. Silverman Scott A. Armstrong Stephen E. Sallan
Journals: Blood (117 papers)Leukemia (54 papers)Pediatric Blood & Cancer (30 papers)British Journal of Haematology (22 papers)Haematologica (22 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Rob Pieters

505 papers receiving 22.5k citations

Hit Papers

6 papers align trajectories log scale

Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia 2023 · 83 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 New England Journal of Medicine
2015 Journal of Clinical Oncology
2010 Cancer
2009 The Lancet Oncology
2007 The Journal of Experimental Medicine
2001 Nature Genetics

Peers

Countries citing papers authored by Rob Pieters

Since Specialization

Citations

This map shows the geographic impact of Rob Pieters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Pieters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Pieters more than expected).

Fields of papers citing papers by Rob Pieters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Pieters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Pieters. The network helps show where Rob Pieters may publish in the future.

Co-authors

The 25 scholars most cited alongside Rob Pieters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob Pieters Line = papers co-authored together Rob Pieters links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical presentation and outcome of invasive mould disease in paediatric patients with acute lymphoblastic leukaemia SHILAP Revista de lepidopterología ·叶文浩, Hadrien Theveneau, Wim J. E. Tissing, Rob Pieters, Louis Bont, Roger J. M. Brüggemann, Tom F.W. Wolfs	2024	3
2	Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population‐based study International Journal of Cancer ·黄黎敏, Maya Schulpen, Semadi Gutomo, An Van Damme, Rob Pieters, K. Henau, Nancy Van Damme, Henrike E. Karim‐Kos	2024	1
3	Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia Blood Cancer Journal ·Martov AG, C-I Li, Helena J. H. van der Pal, Dorine Bresters, Marc Bierings, Jacqueline J. Loonen, Andrica C. H. de Vries, Marloes Louwerens, Maria M.W. Koopman, Marry M. van den Heuvel‐Eibrink, Margriet van der Heiden‐van der Loo, Peter M. Hoogerbrugge, Geert O. Janssens, Ronald R. de Krijger, Cécile M. Ronckers, Rob Pieters, Leontien C.M. Kremer, Jop C. Teepen	2024	3
4	Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design European Journal of Cancer ·Annelienke M. van Hulst, Erica L T van den Akker, A.P. Salzwedel, Marta Fiocco, D Arru, Raphaële R. L. van Litsenburg, Saskia M.F. Pluijm, C. Michel Zwaan, Hanneke M. van Santen, Rob Pieters, Andrea W.M. Evers, Martha A. Grootenhuis, Marry M. van den Heuvel‐Eibrink	2023	5
5	Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations SHILAP Revista de lepidopterología ·Syida Aameera Yakuth, J. Rothkaehl, Aurélie Boeree, Edwin Sonneveld, Anthony V. Moorman, A T Bley, Rosemary Sutton, H. Berna Beverloo, Rob Pieters, C. Michel Zwaan, Monique L. den Boer, Judith M. Boer	2023	2
6	Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important? JCO Precision Oncology ·Annelienke M. van Hulst, Martha A. Grootenhuis, A.P. Salzwedel, Raphaële R. L. van Litsenburg, 何金铭, Bertrand D. van Zelst, Linda Broer, Saskia M.F. Pluijm, Rob Pieters, Marta Fiocco, Erica L T van den Akker, Marry M. van den Heuvel‐Eibrink	2023	2
7	Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy SHILAP Revista de lepidopterología ·Amanbir Sokhi, 和男安達, 오익환, Tania Meyers, Wim J. E. Tissing, Rob Pieters, Inge M. van der Sluis, Alejandra Galán Palacio	2022	1
8	T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies Blood Cancer Discovery ·Valentina Cordo’, Asghar Vatani Oskouie, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink	2020	66
9	Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL Molecular Cancer Therapeutics ·Michela Bardini, Luca Trentin, Francesca Rizzo, Margherita Vieri, Angela Maria Savino, Patricia Garrido Castro, Grazia Fazio, Eddy H.J. Van Roon, L. D. H. C. S. Da Conceição, Nicholas Smithers, Rab K. Prinjha, Geertruy te Kronnie, Giuseppe Basso, Ronald W. Stam, Rob Pieters, Andrea Biondi, Giovanni Cazzaniga	2018	15
10	MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML Oncogene ·BioSig Tech, T C J M Arentsen-Peters, Askar Obulkasim, Daria G. Valerio, Edwin Sonneveld, Ю Б Житков, Válerie de Haas, Dirk Reinhardt, M Zimmermann, Jan Trka, André Baruchel, Rob Pieters, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Maarten Fornerod	2017	14
11	Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy Journal of Clinical Oncology ·Ajay Vora, Anita Andreano, Ching‐Hon Pui, Stephen P. Hunger, Martin Schrappe, Anja Moericke, Andrea Biondi, Gabriele Escherich, Lewis B. Silverman, Nicholas Goulden, Mervi Taskinen, Rob Pieters, Keizo Horibe, Meenakshi Devidas, Franco Locatelli, Maria Grazia Valsecchi	2016	75
12	A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia Blood ·Wing H. Tong, Rob Pieters, Gertjan J.L. Kaspers, D. Maroeska W. M. te Loo, Marc Bierings, Cor van den Bos, Wouter J.W. Kollen, Wim C.J. Hop, Claudia Lanvers‐Kaminsky, Mary V. Relling, Wim J. E. Tissing, Inge M. van der Sluis	2014	155
13	Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL Blood ·Arian van der Veer, Esmé Waanders, Rob Pieters, Marieke E. Willemse, Simon V. van Reijmersdal, Lisa J. Russell, Christine J. Harrison, William E. Evans, Vincent H. J. van der Velden, Peter M. Hoogerbrugge, Frank N. van Leeuwen, Gabriele Escherich, Martin A. Horstmann, Larissa Gomes Espinosa, Dimitris Rizopoulos, Hester A. de Groot‐Kruseman, Edwin Sonneveld, Roland P. Kuiper, Monique L. den Boer	2013	187
14	Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium Journal of Clinical Oncology ·C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud, Shahnaz Begum Neena, Thomas Lehrnbecher, Vincent H. J. van der Velden, Berna Beverloo, Monique L. den Boer, Rob Pieters, Dirk Reinhardt, Michael Dworzak, Julie Rosenberg, George Manos, Shruti Agrawal, Lewis C. Strauss, André Baruchel, Pamela Kearns	2013	66
15	Gene expression profiling–based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants Blood ·Ronald W. Stam, Pauline Schneider, I. A. Kvint, Tina Vukasovič, Dominique J. P. M. Stumpel, Renée X. de Menezes, Paola De Lorenzo, Maria Grazia Valsecchi, Rob Pieters	2009	110
16	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	2009	80
17	Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial Blood ·Rob Pieters, Inge M. Appel, Ayuka Orimo, Mascha Sofie Stadler, Uwe Pichlmeier, Kok Alfred Chee Jee, Eline G. Visser, Derriawan dan Djoharsyah Mx	2008	67
18	Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia Cancer Research ·黑子, W. Nicholas Haining, Sascha Ansén, Zhinan Xia, Scott A. Armstrong, Nilufer P. Seth, Paolo Ghia, Monique L. den Boer, Rob Pieters, Stephen E. Sallan, Lee M. Nadler, Angelo A. Cardoso	2005	28
19	CALENDAR British Journal of Cancer ·Stefan G. E. Roberts, Jose A Canas, Gertjan J.L. Kaspers, Rob Pieters, Pieter Sonneveld, A. Veerman	2000	1
20	CALENDAR British Journal of Cancer ·Stefan G. E. Roberts, Gertjan J.L. Kaspers, Rob Pieters, Pieter Sonneveld, A. Veerman	2000	1

About Rob Pieters

Rob Pieters is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Genetics and Oncology, having authored 518 papers that have together received 22.9k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (343 papers), Childhood Cancer Survivors' Quality of Life (191 papers), Acute Myeloid Leukemia Research (143 papers), Chronic Myeloid Leukemia Treatments (75 papers), Chronic Lymphocytic Leukemia Research (34 papers), Epigenetics and DNA Methylation (28 papers), Neuroblastoma Research and Treatments (26 papers) and Adolescent and Pediatric Healthcare (22 papers). The work is most often cited by research in Hematology (7.9k citations), Public Health, Environmental and Occupational Health (11.4k citations), Pediatrics, Perinatology and Child Health (6.3k citations), Genetics (1.8k citations) and Oncology (4.2k citations). Rob Pieters has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Monique L. den Boer, A. Veerman, Marry M. van den Heuvel‐Eibrink, Gertjan J.L. Kaspers, Jules P.P. Meijerink, Lewis B. Silverman, Scott A. Armstrong, Stephen E. Sallan, Ronald W. Stam and Todd R. Golub. Their work appears in journals such as Blood, Leukemia, Pediatric Blood & Cancer, British Journal of Haematology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact